GILD Gilead Sciences Inc

Today, www.EquityMarketsInc.com announced its research report highlighting United Therapeutics Corporation (NASDAQ: UTHR) and Gilead Sciences, Inc. (NASDAQ: GILD). Full content and research is available at www.EquityMarketsInc.com/research.php.

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

Equity Markets has reviewed United Therapeutics Corporation as a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients. Recently, the company announced its most recent Phase III trial for oral treprostinil failed to meet its primary endpoint. The full research report on United Therapeutics Corporation (NASDAQ: UTHR) is available here: www.EquityMarketsInc.com/researchfile4634.php.

Equity Markets is covering Gilead Sciences, Inc. as a biopharmaceutical company with a focus on the development and commercialization of human therapeutics for life threatening diseases. The full research report on Gilead Sciences, Inc. (NASDAQ: GILD) is available here: www.EquityMarketsInc.com/researchfile4891.php.

About Equity Markets Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact: Samuel Littman Email Contact www.EquityMarketsInc.com